• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

移植前和移植后项目评分与候选者列名后的死亡率的相关性。

Association of pretransplant and posttransplant program ratings with candidate mortality after listing.

机构信息

Scientific Registry of Transplant Recipients, Minneapolis Medical Research Foundation, Minneapolis, MN, USA.

Department of Medicine, Hennepin County Medical Center, University of Minnesota, Minneapolis, MN, USA.

出版信息

Am J Transplant. 2019 Feb;19(2):399-406. doi: 10.1111/ajt.15032. Epub 2018 Aug 21.

DOI:10.1111/ajt.15032
PMID:30040191
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6837730/
Abstract

The Scientific Registry of Transplant Recipients (SRTR) is responsible for understandable reporting of program metrics, including transplant rate, waitlist mortality, and posttransplant outcomes. SRTR developed five-tier systems for each metric to improve accessibility for the public. We investigated the associations of the five-tier assignments at listing with all-cause candidate mortality after listing, for candidates listed July 12, 2011-June 16, 2014. Transplant rate evaluations with one additional tier were associated with lower mortality after listing in kidney (hazard ratio [HR], 0.95 ), liver (HR, 0.90 ), and heart (HR, 0.96 ) transplantation. For lung transplant patients, mortality after listing was highest at programs with above- and below-average transplant rates and lowest at programs with average transplant rates, suggesting that aggressive acceptance behavior may not always provide a survival benefit. Waitlist mortality evaluations with one additional tier were associated with lower mortality after listing in kidney (HR, 0.96 ) transplantation, and posttransplant graft survival evaluations with one additional tier were associated with lower mortality after listing in lung (HR, 0.94 ) transplantation. Transplant rate typically had the strongest association with mortality after listing, but the strength of associations differed by organ.

摘要

移植受者科学登记处(SRTR)负责以通俗易懂的方式报告计划指标,包括移植率、候补者死亡率和移植后结果。SRTR 为每个指标开发了五级系统,以提高公众的可访问性。我们研究了在 2011 年 7 月 12 日至 2014 年 6 月 16 日期间列出的五个级别与列出后的所有原因候选者死亡率之间的关联。与一个额外级别相关的移植率评估与列出后的死亡率降低相关,包括肾脏(风险比 [HR],0.95)、肝脏(HR,0.90)和心脏(HR,0.96)移植。对于肺移植患者,在移植率高于和低于平均水平的项目中,列出后的死亡率最高,而在移植率平均的项目中,死亡率最低,这表明积极的接受行为可能并不总是提供生存获益。与一个额外级别相关的候补者死亡率评估与肾脏(HR,0.96)移植后死亡率降低相关,与一个额外级别相关的移植后移植物存活率评估与肺(HR,0.94)移植后死亡率降低相关。移植率通常与列出后的死亡率关联最强,但关联的强度因器官而异。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/e5712e894bca/nihms-1057514-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/77efb6621232/nihms-1057514-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/25d78342cd59/nihms-1057514-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/639f0616c51c/nihms-1057514-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/e5712e894bca/nihms-1057514-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/77efb6621232/nihms-1057514-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/25d78342cd59/nihms-1057514-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/639f0616c51c/nihms-1057514-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3737/6837730/e5712e894bca/nihms-1057514-f0004.jpg

相似文献

1
Association of pretransplant and posttransplant program ratings with candidate mortality after listing.移植前和移植后项目评分与候选者列名后的死亡率的相关性。
Am J Transplant. 2019 Feb;19(2):399-406. doi: 10.1111/ajt.15032. Epub 2018 Aug 21.
2
Comparing Scientific Registry of Transplant Recipients posttransplant program-specific outcome ratings at listing with subsequent recipient outcomes after transplant.比较移植受者注册处(SRTR)移植前特定项目结局评分与移植后受者结局。
Am J Transplant. 2019 Feb;19(2):391-398. doi: 10.1111/ajt.15038. Epub 2018 Aug 31.
3
Functional status at listing predicts waitlist and posttransplant mortality in pediatric liver transplant candidates.在列功能状态预测儿科肝移植候选者的等待名单和移植后死亡率。
Am J Transplant. 2019 May;19(5):1388-1396. doi: 10.1111/ajt.15203. Epub 2018 Dec 31.
4
Transplant Center Variability in Organ Offer Acceptance and Mortality Among US Patients on the Heart Transplant Waitlist.美国心脏移植候补患者中器官提供接受率和死亡率的移植中心变异性。
JAMA Cardiol. 2020 Jun 1;5(6):660-668. doi: 10.1001/jamacardio.2020.0659.
5
Variables of importance in the Scientific Registry of Transplant Recipients database predictive of heart transplant waitlist mortality.在 Scientific Registry of Transplant Recipients 数据库中,对心脏移植候补者死亡率有预测意义的重要变量。
Am J Transplant. 2019 Jul;19(7):2067-2076. doi: 10.1111/ajt.15265. Epub 2019 Feb 13.
6
Dramatic secular changes in prognosis for kidney transplant candidates in the United States.美国肾移植候选人预后的显著长期变化。
Am J Transplant. 2019 Feb;19(2):414-424. doi: 10.1111/ajt.15021. Epub 2018 Aug 14.
7
Heart and lung organ offer acceptance practices of transplant programs are associated with waitlist mortality and organ yield.心脏和肺脏器官移植项目的接受者实践与候补者死亡率和器官供体数量有关。
Am J Transplant. 2018 Aug;18(8):2061-2067. doi: 10.1111/ajt.14885. Epub 2018 May 9.
8
Impact of delayed listing after initiating kidney transplant evaluation on transplant outcomes.启动肾移植评估后延迟登记对移植结果的影响。
Clin Transplant. 2024 May;38(5):e15319. doi: 10.1111/ctr.15319.
9
Variability in donor organ offer acceptance and lung transplantation survival.供体器官接受率和肺移植存活率的差异。
J Heart Lung Transplant. 2020 Apr;39(4):353-362. doi: 10.1016/j.healun.2019.12.010. Epub 2020 Jan 21.
10
Analysis of the waitlist performance and post-transplant outcomes of lung transplant in elderly recipients in Korea: A nationwide cohort study.韩国老年肺移植受者的候补名单表现和移植后结局分析:一项全国性队列研究。
Clin Transplant. 2024 Sep;38(9):e15299. doi: 10.1111/ctr.15299.

引用本文的文献

1
Don't Throw Your Heart Away: Increased Transparency of Donor Utilization Practices in Transplant Center Report Cards Alters How Center Performance Is Evaluated.切勿摒弃爱心:在移植中心报告卡中提高供体使用透明度会改变对中心绩效的评估方式。
Med Decis Making. 2022 Apr;42(3):341-351. doi: 10.1177/0272989X211038941. Epub 2021 Oct 4.
2
Design of a patient-centered decision support tool when selecting an organ transplant center.设计一个以患者为中心的决策支持工具,用于选择器官移植中心。
PLoS One. 2021 May 17;16(5):e0251102. doi: 10.1371/journal.pone.0251102. eCollection 2021.
3
Designing a patient-specific search of transplant program performance and outcomes: Feedback from heart transplant candidates and recipients.

本文引用的文献

1
Program-specific transplant rate ratios: Association with allocation priority at listing and posttransplant outcomes.特定项目的移植率比值:与列表中的分配优先级和移植后结果的关联。
Am J Transplant. 2018 Jun;18(6):1360-1369. doi: 10.1111/ajt.14684. Epub 2018 Mar 3.
2
Standardized Transplantation Referral Ratio to Assess Performance of Transplant Referral among Dialysis Facilities.标准化移植推荐比评估透析机构移植推荐的表现。
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):282-289. doi: 10.2215/CJN.04690417. Epub 2018 Jan 25.
3
Accountability of Dialysis Facilities in Transplant Referral: CMS Needs to Collect National Data on Dialysis Facility Kidney Transplant Referrals.
设计针对移植项目表现和结果的个体化搜索:来自心脏移植候选人和受者的反馈。
Clin Transplant. 2021 Feb;35(2):e14183. doi: 10.1111/ctr.14183. Epub 2020 Dec 19.
4
Kidney transplant program waitlisting rate as a metric to assess transplant access.作为评估移植机会的指标,肾脏移植项目候补名单率。
Am J Transplant. 2021 Jan;21(1):314-321. doi: 10.1111/ajt.16277. Epub 2020 Sep 15.
5
HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.HEP-Net关于在巴基斯坦资源有限环境下失代偿期肝硬化患者腹水及其并发症管理的意见。
Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.
6
Tool to Aid Patients in Selecting a Liver Transplant Center.辅助患者选择肝移植中心的工具。
Liver Transpl. 2020 Mar;26(3):337-348. doi: 10.1002/lt.25715.
7
Comparing Pretransplant and Posttransplant Outcomes When Choosing a Transplant Center: Focus Groups and a Randomized Survey.比较移植中心选择时的移植前和移植后结果:焦点小组和随机调查。
Transplantation. 2020 Jan;104(1):201-210. doi: 10.1097/TP.0000000000002809.
8
How patients choose kidney transplant centers: A qualitative study of patient experiences.患者如何选择肾移植中心:一项关于患者体验的定性研究。
Clin Transplant. 2019 May;33(5):e13523. doi: 10.1111/ctr.13523. Epub 2019 Apr 21.
透析机构在移植转诊中的责任:医疗保险和医疗补助服务中心需要收集关于透析机构肾移植转诊的全国性数据。
Clin J Am Soc Nephrol. 2018 Feb 7;13(2):193-194. doi: 10.2215/CJN.13741217. Epub 2018 Jan 25.
4
Offer acceptance practices and geographic variability in allocation model for end-stage liver disease at transplant.肝移植终末期肝病分配模型中的供体接受行为和地域差异。
Liver Transpl. 2018 Apr;24(4):478-487. doi: 10.1002/lt.25010.
5
A kidney offer acceptance decision tool to inform the decision to accept an offer or wait for a better kidney.一个肾脏供体接受决策工具,用于告知接受供体或等待更好肾脏的决策。
Am J Transplant. 2018 Apr;18(4):897-906. doi: 10.1111/ajt.14506. Epub 2017 Oct 17.
6
A Five-Tier System for Improving the Categorization of Transplant Program Performance.提高移植项目绩效分类的五级系统。
Health Serv Res. 2018 Jun;53(3):1979-1991. doi: 10.1111/1475-6773.12726. Epub 2017 Jun 13.
7
OPTN/SRTR 2015 Annual Data Report: Kidney.器官获取与移植网络/器官共享联合网络2015年度数据报告:肾脏
Am J Transplant. 2017 Jan;17 Suppl 1(Suppl 1):21-116. doi: 10.1111/ajt.14124.
8
OPTN/SRTR 2015 Annual Data Report: Lung.器官获取与移植网络/器官共享联合网络2015年度数据报告:肺脏
Am J Transplant. 2017 Jan;17 Suppl 1:357-424. doi: 10.1111/ajt.14129.
9
OPTN/SRTR 2015 Annual Data Report: Liver.器官获取与移植网络/器官共享联合网络2015年度数据报告:肝脏
Am J Transplant. 2017 Jan;17 Suppl 1:174-251. doi: 10.1111/ajt.14126.
10
Survival Benefit of Lung Transplantation in the Modern Era of Lung Allocation.现代肺分配时代肺移植的生存获益
Ann Am Thorac Soc. 2017 Feb;14(2):172-181. doi: 10.1513/AnnalsATS.201606-507OC.